Xin Lang Cai Jing·2025-10-27 21:04Group 1 - Newman Mining is considering acquiring Barrick Gold's Nevada gold mine assets, currently holding a minority stake in the joint venture and exploring various transaction options [1] - Eli Lilly plans to acquire gene therapy company Adverum for $3.56 per share, with potential additional value of up to $8.91 per share based on specific conditions [2] - Qingdao Beer has terminated its acquisition of 100% equity in Jimo Yellow Wine due to unmet conditions in the equity transfer agreement, incurring no liability [3] Group 2 - China Tungsten High-Tech plans to acquire 99.9733% equity in Hunan Yuanjing Tungsten Industry for 821 million yuan, constituting a related party transaction but not a major asset restructuring [4] - Skyworth Group intends to acquire a 40% stake in Fengchi Electronics for 116 million yuan and will inject an additional 104 million yuan into the company [5] - Yayi Chemical Group is set to acquire approximately 60% equity in Beijing Xinnuo Haibo Petrochemical Technology, a leading chemical gas company in China [6] Group 3 - Shandong Steel plans to acquire 100% equity in Laiwu Steel Group Yingshan Type Steel for 714 million yuan, making it a wholly-owned subsidiary [7] - Weston intends to acquire 36.748% of Liangtou Technology for 106.7 million yuan and will inject an additional 53.27 million yuan into the company [8] - Delong Holdings' major shareholder plans to transfer 29.64% of its shares to Dongyang Noxin Chip Materials, potentially leading to a change in control [9] Group 4 - Jinchun Co. plans to acquire 51% equity in Jincheng Source Material Technology for 51.918 million yuan, making it a controlling subsidiary [10] - Shenlian Biology's subsidiary has completed an investment to gain control over the joint venture Shizhi Yuan, which will be consolidated into Shenlian's financial statements [11] - Fuda Alloy intends to acquire 52.61% of Zhejiang Guangda Electronics for 352 million yuan, which is expected to increase total assets but also raise the debt ratio by over 10 percentage points to 77.23% [12] Group 5 - Suzhou Planning and Design Institute has completed the acquisition of 80% equity in Kunshan Development Zone Architectural Design Institute for 6.6537 million yuan [13] - Yingtang Intelligent Control plans to acquire 100% of Guilin Guanglong Integrated Technology and 76% of Shanghai Aojian Microelectronics through a combination of stock issuance and cash payment [14] - Novartis has announced the acquisition of Avidity Biosciences, focusing on RNA therapy delivery to muscle tissues [15] Group 6 - WuXi AppTec plans to sell equity in its subsidiary to Hillhouse Capital for a base price of 2.8 billion yuan [16]